This pragmatic randomized controlled study aimed to evaluate the effectiveness and safety of moxibustion therapy on overactive bladder (OAB) patients.
Patients who diagnosed as overactive bladder aged 20 to 75 years old will be divided into two groups, one is moxibustion-therapy and the other is waiting-list group. Patients who belong to moxibustion therapy group will be treated moxibustion for 12 times by a Korean Medicine doctor. Patients who belong to waiting-list group will be prohibited to get any treatment including moxibustion for relieve the symptoms of overactive bladder, and the same moxibustion therapy with moxbiustion-therapy group will be conducted after 4 weeks. Overactive bladder symptom score (OABSS), overactive bladder-validated 8-question (OAB-V8) will be measured to evaluate the effectiveness. The number of side effect will be measured to evaluate the safety. The skin temperature of CV4, SP6 and LR3, and the tympanic temperature will be measured to study treatment mechanism.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
24
The treatment schedule is three times per week for four weeks. Indirect moxa pillars and indirect-container moxibustion will be used.
National Clinical Research Center, Korean Medicine Hospital, Pusan National University
Yangsa, Kyungsangnamdo, South Korea
Overactive bladder-validated 8-questions
This is to measure how the patients have been bothered by OAB.
Time frame: 4 weeks
Overactive bladder symptom scores
self-administered questionnaire about daytime frequency, nighttime frequency, urgency and urgency incontinence.
Time frame: 4, 8 weeks
The skin temperature of CV4, SP6 and LR3
this is to establish the foundation of researching moxibustion-therapy mechanism.
Time frame: 4, 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.